Lipocine Inc. (LPCN) Analyst Estimates Annual - Discounting Cash Flows
LPCN
Lipocine Inc.
LPCN (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2019
12-31
2018
12-31
Number of Analysts 1 1 2 2 2 1 1 1 1 1 1
Estimated Revenue
Low 5.16 1.62 0.701 0.4 0.394 6.03 -4.34 1.4 2.95 0.157 0.329
Average 8.84 2.77 1.2 0.56 0.799 10.32 -3.07 1.81 3.75 0.2 0.419
High 12.51 3.93 1.7 0.72 1.2 14.61 -1.79 2.21 4.55 0.242 0.508
Estimated EBITDA
Low 0.902 0.283 0.123 0.07 0.069 1.05 -0.759 -0.012 0.115 0.006 0.013
Average 1.54 0.485 0.21 0.098 0.14 1.8 -0.536 -0.01 0.146 0.008 0.016
High 2.19 0.687 0.297 0.126 0.21 2.55 -0.313 -0.007 0.177 0.009 0.02
Estimated EBIT
Low 0.899 0.282 0.122 0.07 0.069 1.05 -0.756 -0.012 0.115 0.006 0.013
Average 1.54 0.483 0.209 0.097 0.139 1.8 -0.534 -0.01 0.146 0.008 0.016
High 2.18 0.684 0.296 0.125 0.21 2.54 -0.312 -0.007 0.177 0.009 0.02
Estimated Net Income
Low -4.18 -7.52 -9.19 -9.11 -14.83 -6.1 -24.98 -14.67 -16.77 -57.16 -60.59
Average -2.71 -4.88 -5.96 -8.49 -9.63 -5.37 -16.35 -11.35 -13.14 -44.79 -47.48
High -1.25 -2.24 -2.74 -7.86 -4.42 -1.82 -7.45 -8.03 -9.5 -32.38 -34.32
Estimated SGA Expenses
Low 8.45 2.65 1.15 0.655 0.645 9.87 -7.1 11.66 24.59 1.31 2.74
Average 14.46 4.54 1.96 0.916 1.31 16.89 -5.02 15.05 31.26 1.67 3.49
High 20.47 6.43 2.78 1.18 1.97 23.91 -2.93 18.43 37.9 2.02 4.23
Estimated EPS
Low -0.77 -1.39 -1.69 -1.68 -2.73 -1.12 -4.61 -2.78 -3.18 -10.85 -11.5
Average -0.5 -0.9 -1.1 -1.56 -1.77 -0.73 -2.99 -2.15 -2.49 -8.5 -9.01
High -0.23 -0.414 -0.506 -1.45 -0.816 -0.335 -1.37 -1.52 -1.8 -6.14 -6.51
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us